Download PDF
Nuklearmedizin 2015; 54(04): N32-N33
DOI: 10.1055/s-0037-1616615
Case report
Schattauer GmbH

Pancreatic VIPoma visualized by 68Ga DOTA-NOC PET-CT

I. Wimmer
1   University Hospital St. Pölten, Austria
,
G. Minear
1   University Hospital St. Pölten, Austria
,
R. Brustbauer
1   University Hospital St. Pölten, Austria
,
P. Götzinger
1   University Hospital St. Pölten, Austria
,
K. Dam
1   University Hospital St. Pölten, Austria
› Author Affiliations
Further Information

Publication History

received: 06 January 2015

accepted in revised form: 20 April 2015

Publication Date:
12 January 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ro C, Chai W, Yu VE, Yu R. Pancreatic neuroendocrine tumors: biology, diagnosis and treatment. Chin J Cancer 2013; 32: 312-324.
    CrossrefPubMedGoogle Scholar
  • 2 Balachandran A, Tamm EP, Bhosale PR. et al. Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 2013; 38: 342-357.
    CrossrefPubMedGoogle Scholar
  • 3 Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol 2012; 26: 737-753.
    CrossrefPubMedGoogle Scholar
  • 4 Camera L, Severino R, Faggiano A. et al. Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma. World J Radiol 2014; 6: 840-845.
    CrossrefPubMedGoogle Scholar
  • 5 Imeriale A, Rust E, Gabriel S. et al. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. J Nucl Med 2014; 55: 367-372.
    CrossrefPubMedGoogle Scholar
  • 6 Hartmann H, Freudenberg R, Oehme L. et al. Dosimetric measurements of 68Ga-high affinity DOTATATE: twins in spirit part III. Nuklearmedizin 2014; 53: 211-216.
    Article in Thieme ConnectPubMedGoogle Scholar